Pascale Witz

Ms. Witz is a highly accomplished business leader and advisor with nearly three decades of global pharmaceutical and healthcare management experience. Ms. Witz previously served as Executive Vice President of Global Diabetes and Cardiovascular of Sanofi S.A., where she launched multiple medicines and strengthened the company pipeline through licensing and partnerships, as well as on Sanofi’s executive committee. Prior to Sanofi, she held positions of increasing responsibility at GE Healthcare, most recently serving as President and CEO of its $2 billion pharmaceutical diagnostics business.

Ms. Witz received a Master of Business Administration in Economics and Marketing from INSEAD, Fontainebleau, France, and an MSc in Biochemistry from INSA Lyon, France. She currently serves on the Board of Directors for Horizon Therapeutics Plc, PerkinElmer, Inc. and Regulus Therapeutics, Inc. and the Global Alzheimer’s Platform Foundation, a non-profit organization dedicated to accelerating the delivery of innovative therapies to those affected by Alzheimer’s disease.